1. Home
  2. THG vs AMRX Comparison

THG vs AMRX Comparison

Compare THG & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Insurance Group Inc

THG

Hanover Insurance Group Inc

N/A

Current Price

$217.29

Market Cap

7.9B

Sector

Finance

ML Signal

N/A

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

N/A

Current Price

$20.16

Market Cap

6.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
THG
AMRX
Founded
1852
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
6.4B
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
THG
AMRX
Price
$217.29
$20.16
Analyst Decision
Hold
Strong Buy
Analyst Count
8
7
Target Price
★ $237.75
$22.71
AVG Volume (30 Days)
223.7K
★ 2.1M
Earning Date
10-28-2026
10-29-2026
Dividend Yield
★ 1.77%
N/A
EPS Growth
55.21
★ 157.89
EPS
★ 10.58
0.37
Revenue
★ $6,594,400,000.00
N/A
Revenue This Year
$2.03
$4.54
Revenue Next Year
$4.15
$9.14
P/E Ratio
★ $20.74
$54.91
Revenue Growth
★ 5.72
N/A
52 Week Low
$166.54
$9.56
52 Week High
$236.07
$21.18

Technical Indicators

Market Signals
Indicator
THG
AMRX
Relative Strength Index (RSI) 36.35 64.58
Support Level $203.36 $16.59
Resistance Level $233.50 $21.18
Average True Range (ATR) 3.98 0.93
MACD -1.32 0.19
Stochastic Oscillator 6.59 79.20

Price Performance

Historical Comparison
THG
AMRX

About THG Hanover Insurance Group Inc

The Hanover Insurance Group Inc is a holding company whose primary business is offering property and casualty insurance products and services. The company markets itself through independent agents and brokers in the United States while conducting business through Hanover Insurance, Citizens and other THG subsidiaries. The company conducts business operations through four operating segments: Core Commercial, Specialty, Personal Lines, and Other. The company operates an investment portfolio that is exposed to fixed-income securities.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: